What are Contraceptives and why is its market booming?



Contraceptives Market report from DelveInsight provides an in-depth analysis of Contraceptives, as well as historical and forecasted market trends in the global market (North-America, Europe, Asia Pacific and Rest of the world).

Contraceptives Overview:

Contraceptives are products that help form either physical or chemical barriers against the fusion of gametes or prevent the implantation of the fertilized egg from taking place.

To Know in detail about the Contraceptives market outlook, treatment scenario and market trends, Click here; Contraceptives Market Insights 

What are the Key Highlights from the Contraceptives Market Report?

The Contraceptives market size was valued at USD 24.17 Billion in the year 2021 and is expected to grow at a CAGR of 5.19% during the forecasted period (2022-2027). In October 2021, Bayer and the US biotech company Daré Bioscience collaborated to develop a hormone-free monthly contraceptive. The device is a ring that is inserted into the vagina, providing contraception over three weeks without any action required by the user around the time of intercourse. In April 2021, the FDA approved Nextstellis by Mayne Pharma, a combination of drospirenone and estetrol tablets to prevent pregnancy. The first combination pill contains naturally occurring estrogen.

Contraceptives Market Drivers are - The increasing prevalence of breast cancer globally, Rising incidence of cardiovascular diseases, Rising prevalence of geriatric population, and Favorable Reimbursement Coverage. Contraceptives Market Barriers: high cost of Contraceptives systems, complications related to surgical procedures such as data security & privacy issues.

The market report on Contraceptives includes an overview of the industry as well as a PEST Analysis. The report also examines market drivers, market constraints, and unmet medical needs in order to identify the greatest prospects and analyze the market's underlying potential. 

Contraceptives Market Insights: 

The dynamics of the Contraceptives market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2022-2032. 

The Contraceptives market has been occupied by some leading companies in the manufacturing of the Contraceptives depending on the geography and the product type. 

The Contraceptives market is broad, with a large variety of products accessible, and Contraceptives key companies such as Teva Pharmaceutical Industries Ltd, TherapeuticsMD, Inc., AbbVie Inc., Bayer AG, The Cooper Companies Inc., FemCap Inc, Veru Inc., Meril Life Sciences Pvt. Ltd., Pregna International Limited., Reckitt Benckiser Group PLC., Viatris Inc., EUROGINE, S.L, Gedeon Richter Plc., Agile Therapeutics., Evofem Biosciences, Inc., Amneal Pharmaceuticals LLC., Shanghai Dahua Pharmaceutical Co., Ltd., Pfizer Inc., Contech Devices Private Limited, Cupid Limited, are present. 

What are the key benefits of the Contraceptives market report?


  1. Contraceptives market report covers a descriptive overview and comprehensive insight of the Contraceptives market trends and Contraceptives market globally.

  2. Contraceptives market report provides a global historical and forecasted market covering drug outreach globally.

  3. The Contraceptives market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Contraceptives market.

To know more about Contraceptives Market Analysis, visit @ Contraceptives Market Report

Comments

Post a Comment

Popular posts from this blog

Amyotrophic Lateral Sclerosis Recent Developments and Upcoming Therapies?

Image
  What is Amyotrophic Lateral Sclerosis? Amyotrophic Lateral Sclerosis ( ALS) is a nervous system disease that weakens muscles and impacts physical function. The treatment landscape for amyotrophic lateral sclerosis is rigorous and comprises multidisciplinary care, including physical therapy, speech therapy, food counseling, heat or whirlpool therapy, and other practices. The following medications have been licensed for the treatment of amyotrophic lateral sclerosis: RILUZOLE, RADICAVA, TIGLUTIK, EXSERVAN, and RELYVRIO . There is currently no viable treatment to slow or stop the disease's progression from ALS. Palliative care and symptom management are the cornerstones of ALS treatment. Riluzole and its formulations approval journey The FDA authorized riluzole in 1995 as the first medication for the treatment of ALS. Many other nations recommended the medication as the first-line therapy for the treatment of ALS throughout the next decades. It is advised to take riluzole to increa
Read more

Seasonal Influenza Market: Insights, Epidemiology, and Forecast for 2032

Image
  What is Seasonal Influenza? Seasonal influenza , also known as the flu, is a contagious respiratory illness caused by influenza viruses. It is characterized by fever, cough, sore throat, body aches, fatigue, and sometimes respiratory symptoms. Influenza viruses circulate worldwide, and seasonal outbreaks occur annually, usually during the winter months in temperate regions. What is the Seasonal Influenza Market Size in 7MM? The seasonal influenza market size in the 7MM (Seven Major Markets) is expected to witness significant growth in the forecast period. The increasing prevalence of influenza cases, rising awareness about vaccination, and advancements in treatment options are key factors driving market growth. According to market research, the seasonal influenza market is projected to reach $X billion by 2032. Who are the leading companies in the Seasonal Influenza Market Landscape? The seasonal influenza market landscape is highly competitive, with several leading seasonal influen
Read more